Atlas Private Wealth Advisors Amgen Inc Transaction History

Atlas Private Wealth Advisors

$691 Million
Q1 2025

A detailed history of Atlas Private Wealth Advisors transactions in Amgen Inc stock. As of the latest transaction made, Atlas Private Wealth Advisors holds 5,590 shares of AMGN stock, worth $1.62 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares

5,590

Previous 5,665 1.32%

Holding current value

$1.62 Million

Previous $1.48 Million 17.95%

% of portfolio

0.25%

Previous 0.21%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 17, 2025	SELL	$258.59 - $327.36 $19,394 - $24,552	-75 Reduced 1.32%	5,590 $1.74 Million
Q4 2024 Jan 21, 2025	BUY	$258.78 - $328.31 $10,609 - $13,460	41 Added 0.73%	5,665 $1.48 Million
Q3 2024 Oct 08, 2024	BUY	$309.38 - $337.38 $11,137 - $12,145	36 Added 0.64%	5,624 $1.81 Million
Q2 2024 Jul 12, 2024	BUY	$262.75 - $319.31 $738,853 - $897,899	2,812 Added 101.3%	5,588 $1.75 Million
Q1 2024 May 03, 2024	SELL	$268.87 - $324.56 $736,166 - $888,645	-2,738 Reduced 49.66%	2,776 $789,000
Q4 2023 Jan 10, 2024	BUY	$255.7 - $288.46 $9,716 - $10,961	38 Added 0.69%	5,514 $1.59 Million
Q3 2023 Oct 10, 2023	BUY	$218.65 - $271.46 $8,746 - $10,858	40 Added 0.74%	5,476 $1.47 Million
Q2 2023 Aug 04, 2023	BUY	$214.27 - $253.37 $656,737 - $776,579	3,065 Added 129.27%	5,436 $1.21 Million
Q1 2023 Apr 12, 2023	BUY	$225.79 - $275.2 $4,741 - $5,779	21 Added 0.89%	2,371 $573,000
Q4 2022 Feb 14, 2023	SELL	$229.03 - $291.01 $30,690 - $38,995	-134 Reduced 5.39%	2,350 $617,000
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $24,017 - $27,087	107 Added 4.5%	2,484 $560,000
Q2 2022 Aug 15, 2022	BUY	$230.71 - $256.74 $461 - $513	2 Added 0.08%	2,377 $578,000
Q1 2022 Apr 26, 2022	SELL	$219.27 - $242.57 $36,179 - $40,024	-165 Reduced 6.5%	2,375 $574,000
Q4 2021 Apr 21, 2022	BUY	$198.88 - $227.6 $397 - $455	2 Added 0.08%	2,540 $571,000
Q3 2021 Oct 26, 2021	BUY	$212.27 - $248.7 $424,752 - $497,648	2,001 Added 372.63%	2,538 $540,000
Q2 2021 Aug 02, 2021	BUY	$233.58 - $259.14 $10,043 - $11,143	43 Added 8.7%	537 $131,000
Q1 2021 Apr 28, 2021	SELL	$221.91 - $258.6 $9,542 - $11,119	-43 Reduced 8.01%	494 $123,000
Q2 2020 Aug 14, 2020	BUY	$197.81 - $242.74 $106,223 - $130,351	537 New	537 $127,000

Others Institutions Holding AMGN

# of Institutions

3,310

Shares Held

429M

Call Options Held

8.06M

Put Options Held

7.7M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $155B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Atlas Private Wealth Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Atlas Private Wealth Advisors with notifications on news.

Account

Atlas Private Wealth Advisors Amgen Inc Transaction History